Clinical utility of the 21-gene assay in predicting response to neoadjuvant endocrine therapy in breast cancer: A systematic review and meta-analysis

Clinical utility of the 21-gene assay in predicting response to neoadjuvant endocrine therapy in breast cancer: A systematic review and meta-analysis

Introduction: OncotypeDX© Recurrence Score (RS) is a multigene panel used to aid therapeutic decision making in early-stage, estrogen receptor positive (ER+)/human epidermal growth factor receptor-2 negative (HER2-) breast cancer. Aim: To compare responses to neoadjuvant endocrine therapy (NET) in p...

Full description

Bibliographic Details
Main Authors: M.G. Davey, É.J. Ryan, M.R. Boland, M.K. Barry, A.J. Lowery, M.J. Kerin
Format: Article
Language:English
Published: Elsevier 2021-08-01
Series:Breast
Subjects:
Breast cancer
Genomics
Endocrine therapy
Personalised medicine
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977621003726

Internet

http://www.sciencedirect.com/science/article/pii/S0960977621003726

Similar Items